School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Edjah Nduom

  • Department of Neurosurgery
    Professor
  • (404) 778-7623
  • edjah.k.nduom@emory.edu
  • Website
  • Website
  • Website
  • Emory University School of Medicine
    Department of Neurosurgery
    1365 Clifton Rd, Suite 2200B
Head shot of Edjah Nduom

Overview

Edjah K. Nduom, MD, FAANS, is the Daniel Louis Barrow Endowed Chair and Professor in the Department of Neurosurgery at Emory University School of Medicine. A fellowship-trained and board certified neurosurgical oncologist, Dr. Nduom's clinical specialty is the surgical management of brain and spinal cord tumors. He is particularly interested in the safe resection of malignant tumors located in eloquent areas of the brain, the brainstem and spinal cord.

Dr. Nduom is a member of the Cancer Immunology Research Program at Winship Cancer Institute of Emory University. He holds numerous positions in national and international medical societies. Notably, he is the Scientific Program Chair and Member at Large for the Congress of Neurological Surgeons, Co-Founder of the Society for Neuro-Oncology Sub-Saharan Africa; Bylaws Chair of the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons; and Chair of the Board of Directors of the National Brain Tumor Society.

Dr. Nduom received his MD from University of Pennsylvania in Philadelphia, Pennsylvania. He completed a residency in Neurosurgery at Emory University in Atlanta, Georgia. He completed a Research Fellowship in Neurosurgical Oncology in the Surgical Neurology Branch of the National Institute of Neurological Disorders and Stroke in Bethesda, Maryland, and an additional Neurosurgical Oncology Fellowship at MD Anderson Cancer Center in Houston, Texas.

Dr. Nduom's research focuses on the modulation of the immune system for the treatment of malignant brain tumors. He has presented his translational and clinical work on immune therapy for brain tumors at numerous national and international meetings.

Academic Appointment

Education

Degrees

  • MD from University of Pennsylvania School of Medicine
  • BS, Biomechanical Engineering from Stanford University

Research

Publications

  • Patient-Derived Meningioma Organoids: A Reliable Model for Studying Human Tumor Pathophysiology.
    Cancers (Basel) Volume: 17
    02/05/2025 Authors: Zohdy YM; Jahangiri A; Jacob F; Aksionau A; Alawieh AM; Tong A; Chern B; Maldonado J; Hoang K; Nduom E
  • Mapping the developmental trajectory of human astrocytes reveals divergence in glioblastoma.
    Nat Cell Biol Volume: 27 Page(s): 347 - 359
    02/01/2025 Authors: Sojka C; Wang H-LV; Bhatia TN; Li Y; Chopra P; Sing A; Voss A; King A; Wang F; Joseph K
  • Financial Toxicity in High-Grade Glioma Resection: A Retrospective Analysis.
    World Neurosurg Volume: 194 Page(s): 123477
    02/01/2025 Authors: Stubbs NM; Garner JA; Akinwunmi-Williams T; Jani J; Ngo S; Ma T; Robinson E; Jackson T; Olson J; Huntoon K
  • Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates.
    Nat Commun Volume: 15 Page(s): 8854
    10/14/2024 Authors: Jansen CS; Pagadala MS; Cardenas MA; Prabhu RS; Goyal S; Zhou C; Chappa P; Vo BT; Ye C; Hopkins B
  • A brave new framework for glioma drug development.
    Lancet Oncol Volume: 25 Page(s): e512 - e519
    10/01/2024 Authors: Hotchkiss KM; Karschnia P; Schreck KC; Geurts M; Cloughesy TF; Huse J; Duke ES; Lathia J; Ashley DM; Nduom EK
  • Frailty in patients with IDH-mutant gliomas: experience from a high-volume tumor center.
    J Neurooncol Volume: 168 Page(s): 435 - 443
    07/01/2024 Authors: Bray DP; Stubbs NM; Chow J; Jahangiri A; Nduom EK; Olson JJ; Hoang KB
  • Intramedullary Spinal Cord Tumors: Whole-Genome Sequencing to Assist Management and Prognosis.
    Cancers (Basel) Volume: 16
    01/18/2024 Authors: Mayol Del Valle M; Morales B; Philbrick B; Adeagbo S; Goyal S; Newman S; Frontera NL; Nduom E; Olson J; Neill S
  • TGF- and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma.
    Neurooncol Adv Volume: 6 Page(s): vdad164
    01/01/2024 Authors: Li A; Hancock JC; Quezado M; Ahn S; Briceno N; Celiku O; Ranjan S; Aboud O; Colwell N; Kim SA
  • Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors.
    Curr Treat Options Oncol Volume: 24 Page(s): 1948 - 1961
    12/01/2023 Authors: Ndirangu B; Bryan K; Nduom E
  • Promoting diversity in neurosurgery through a virtual symposium.
    J Neurosurg Volume: 139 Page(s): 1101 - 1108
    10/01/2023 Authors: Charles AJ; Seas A; Corley J; Duvall JB; Owolo E; Abu-Bonsrah N; Elsamadicy AA; Simpson V; Sanusi O; Holly LT
  • Examining the Effect of ALK and EGFR Mutations on Survival Outcomes in Surgical Lung Brain Metastasis Patients.
    Cancers (Basel) Volume: 15
    09/28/2023 Authors: Mannam SS; Bray DP; Nwagwu CD; Zhong J; Shu H-K; Eaton B; Sudmeier L; Goyal S; Deibert C; Nduom EK
  • Tongue Fasciculations and Numbness: A Case of Calcifying Pseudoneoplasm
    Volume: 38 Page(s): S869 - S870
    08/01/2023 Authors: Hudaib S; Stubbs N; Simon L; Blake V; Nduom E; Branson C
  • Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS.
    Res Sq
    03/23/2023 Authors: Jansen CS; Prabhu RS; Pagadala MS; Chappa P; Goyal S; Zhou C; Neill SG; Prokhnevska N; Cardenas M; Hoang KB
  • Mass shootings in the United States: an alarming trend of violence and public health threat.
    J Neurosurg Volume: 138 Page(s): 882 - 883
    03/01/2023 Authors: Spence CA; Eden SV; Pennicooke B; Adogwa O; Holly LT; Welch BG; Mbabuike N; Nduom E; Ashley WW
  • Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis.
    PLoS One Volume: 18 Page(s): e0291068
    01/01/2023 Authors: Nduom EK; Glod J; Brown DA; Fagan M; Dalmage M; Heiss J; Steinberg SM; Peer C; Figg WD; Jackson S
  • Historical determinants of neurosurgical inequities in Africa and the African diaspora: A review and analysis of coloniality.
    PLOS Glob Public Health Volume: 3 Page(s): e0001550
    01/01/2023 Authors: Barthlemy EJ; Diouf SA; Silva ACV; Abu-Bonsrah N; de Souza IAS; Kanmounye US; Gabriel P; Sarpong K; Nduom EK; Lartigue JW
  • Letter to the Editor. Diversity-related studies in neurosurgery: concerns and suggestions.
    J Neurosurg Spine Volume: 37 Page(s): 781 - 782
    11/01/2022 Authors: Holly LT; Ashley WW; Nduom EK; Pennicooke B; Spence CA; Welch BG
  • Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.
    Neuro Oncol Volume: 24 Page(s): 1219 - 1229
    08/01/2022 Authors: Ellingson BM; Gerstner ER; Lassman AB; Chung C; Colman H; Cole PE; Leung D; Allen JE; Ahluwalia MS; Boxerman J
  • Commentary: Time to Steroid Independence After Laser Interstitial Thermal Therapy vs Medical Management for Treatment of Biopsy-Proven Radiation Necrosis Secondary to Stereotactic Radiosurgery for Brain Metastasis.
    Neurosurgery Volume: 90 Page(s): e142 - e143
    06/01/2022 Authors: Del Valle MM; Nduom EK; Olson J; Hoang KB
  • Distinct phenotypic states and spatial distribution of CD8+ Tcell clonotypes in human brain metastases.
    Cell Rep Med Volume: 3 Page(s): 100620
    05/17/2022 Authors: Sudmeier LJ; Hoang KB; Nduom EK; Wieland A; Neill SG; Schniederjan MJ; Ramalingam SS; Olson JJ; Ahmed R; Hudson WH
  • Author Correction: GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models.
    Sci Rep Volume: 12 Page(s): 5615
    04/04/2022 Authors: Sanchez VE; Lynes JP; Walbridge S; Wang X; Edwards NA; Nwankwo AK; Sur HP; Dominah GA; Obungu A; Adamstein N
  • Artificial Neural Networks Predict the Need for Permanent CSF Diversion After Posterior Fossa Tumor Surgery
    Volume: 68 Page(s): 130 - 130
    04/01/2022 Authors: Bray DP; Saad H; Douglas JAM; Grogan D; Dawoud R; Nduom EK; Pradilla G; Olson J; Alawieh AM; Hoang KB
  • Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review.
    J Neurooncol Volume: 157 Page(s): 187 - 195
    03/01/2022 Authors: Grogan D; Bray DP; Cosgrove M; Boucher A; Erwood A; Linder DF; Mendoza P; Morales B; Pradilla G; Nduom EK
  • Guidelines for optimal utilization of social media for brain tumor stakeholders.
    J Neurosurg Volume: 136 Page(s): 335 - 342
    02/01/2022 Authors: Hamidi N; Karmur B; Sperrazza S; Alexieva J; Salmi L; Zacharia BE; Nduom EK; Cohen-Gadol AA; Rutka JT; Mansouri A
  • Commentary: 5-Aminolevulinic Acid-Induced Porphyrin Contents in Various Brain Tumors: Implications Regarding Imaging Device Design and Their Validation.
    Neurosurgery Volume: 90 Page(s): e43 - e44
    02/01/2022 Authors: Bray DP; Hoang KB; Nduom EK; Olson JJ
  • Artificial neural networks predict the need for permanent cerebrospinal fluid diversion following posterior fossa tumor resection.
    Neurooncol Adv Volume: 4 Page(s): vdac145
    01/01/2022 Authors: Bray DP; Saad H; Douglas JM; Grogan D; Dawoud RA; Chow J; Deibert C; Pradilla G; Nduom EK; Olson JJ
  • A scoping review of pediatric microdialysis: A missed opportunity for microdialysis in the pediatric neuro-oncology setting.
    Neurooncol Adv Volume: 4 Page(s): vdac171
    01/01/2022 Authors: Dalmage MR; Nwankwo A; Sur H; Nduom E; Jackson S
  • CHARACTERIZATION OF TUMOR-INFILTRATING CD8+T CELLS IN BRAIN METASTASES
    Volume: 23 Page(s): 91 - 92
    11/01/2021 Authors: Sudmeier L; Hudson W; Hoang K; Nduom E; Neill S; Schniederjan M; Olson J; Ahmed R
  • Defining the Immune Cell Infiltrate of Brain Metastases Before and After Stereotactic Radiosurgery
    Volume: 111 Page(s): E233 - E234
    11/01/2021 Authors: Sudmeier LJ; Hudson W; Hoang KB; Nduom E; Shu HKG; Higgins KA; Olson JJ; Ahmed R
  • Phase I Dose Escalation Trial of Hypofractionated Radiosurgery for Large Intact or Resected Brain Metastases
    Volume: 111 Page(s): S25 - S25
    11/01/2021 Authors: Eaton BR; Chen Z; Butker EK; Gorgens U; Zhong J; Higgins KA; Patel PR; Bradley JD; Hoang KB; Nduom E
  • Phase I Dose Escalation Trial of Hypofractionated Radiosurgery for Large Intact or Resected Brain Metastases.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): S25
    11/01/2021 Authors: Eaton BR; Chen Z; Butker EK; Gorgens U; Zhong J; Higgins KA; Patel PR; Bradley JD; Hoang KB; Nduom E
  • Defining the Immune Cell Infiltrate of Brain Metastases Before and After Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e233 - e234
    11/01/2021 Authors: Sudmeier LJ; Hudson W; Hoang KB; Nduom E; Shu HKG; Higgins KA; Olson JJ; Ahmed R
  • A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma.
    Volume: 89 Page(s): 712 - 719
    09/15/2021 Authors: Khalafallah AM; Rakovec M; Bettegowda C; Jackson CM; Gallia GL; Weingart JD; Lim M; Esquenazi Y; Zacharia BE; Goldschmidt E
  • Vaccination with Irradiated Whole Tumor Cells Pulsed With Phagocytic Agonists, TLR Ligands and Anti-CD40 Antibody Stimulates Antitumor Immune Response Against Metastatic and CNS Tumors
    Volume: 135 Page(s): 61 - 61
    08/01/2021 Authors: Medina R; Wang H; Heiss J; Nduom E; Macyszyn L; Gilbert M; Terabe M; Ho W; Zenka J; Pacak K
  • Vaccination with Irradiated Whole Tumor Cells Pulsed With Phagocytic Agonists, TLR Ligands and Anti-CD40 Antibody Stimulates Antitumor Immune Response Against Metastatic and CNS Tumors
    Volume: 132
    08/01/2021 Authors: Medina R; Wang H; Heiss J; Nduom E; Macyszyn L; Gilbert M; Terabe M; Ho W; Zenka J; Pacak K
  • Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum Investigators.
    Neurosurgery Volume: 89 Page(s): 129 - 132
    06/15/2021 Authors: Nduom EK; Gephart MH; Chheda MG; Suva ML; Amankulor N; Battiste JD; Campian JL; Dacey RG; Das S; Fecci PE
  • Letter: A Call to Action: Increasing Black Representation in Neurological Surgery.
    Neurosurgery Volume: 88 Page(s): E469 - E473
    04/15/2021 Authors: Detchou DK; Onyewuenyi A; Reddy V; Boyke A; Mbabuike N; Ashley WW; Nduom EK
  • Why would a black man volunteer for a government-funded science experiment?
    EClinicalMedicine Volume: 33 Page(s): 100788
    03/01/2021 Authors: Nduom EK
  • SNO 25th anniversary history series: Providing a global platform for communication and exchange in neuro-oncology.
    Neuro Oncol Volume: 22 Page(s): 1551 - 1552
    11/26/2020 Authors: Balogun J; Haynes C; Lwin Z; Nduom E; Puduvalli V; Venere M; Zadeh G
  • Brain Tumor Discussions on Twitter (#BTSM): Social Network Analysis.
    J Med Internet Res Volume: 22 Page(s): e22005
    10/08/2020 Authors: Feliciano JT; Salmi L; Blotner C; Hayden A; Nduom EK; Kwan BM; Katz MS; Claus EB
  • Metastases to the Central Nervous System: A Comprehensive Guide on Current Management and Future Directions.
    Neurosurg Clin N Am Volume: 31 Page(s): xiii - xiv
    10/01/2020 Authors: Nduom EK; Olson JJ
  • Induction of Immune Response Against Metastatic Tumors via Vaccination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibody (MBTA).
    Adv Ther (Weinh) Volume: 3
    09/01/2020 Authors: Medina R; Wang H; Caisov V; Cui J; Indig IH; Uher O; Ye J; Nwankwo A; Sanchez V; Wu T
  • Variations in attitudes towards stereotactic biopsy of adult diffuse midline glioma patients: a survey of members of the AANS/CNS Tumor Section.
    J Neurooncol Volume: 149 Page(s): 161 - 170
    08/01/2020 Authors: Lynes J; Acquaye AA; Sur H; Nwankwo A; Sanchez V; Vera E; Wu T; Theeler B; Armstrong TS; Gilbert MR
  • GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models.
    Sci Rep Volume: 10 Page(s): 11003
    07/03/2020 Authors: Sanchez VE; Lynes JP; Walbridge S; Wang X; Edwards NA; Nwankwo AK; Sur HP; Dominah GA; Obungu A; Adamstein N
  • A first-in-human phase I single-agent dose-escalation, food effect and dose expansion study of oral ONC206 in recurrent and rare primary central nervous system neoplasms.
    Volume: 38
    05/20/2020 Authors: Theeler BJ; Jung J; Burton E; Gonzalez J; Leeper H; Wu J; Nduom E; Zaghloul K; Ray-Chaudhury A; Quezado M
  • Biomarkers for immunotherapy for treatment of glioblastoma.
    J Immunother Cancer Volume: 8
    05/01/2020 Authors: Lynes JP; Nwankwo AK; Sur HP; Sanchez VE; Sarpong KA; Ariyo OI; Dominah GA; Nduom EK
  • Vaccination with Irradiated Whole Tumor Cells Pulsed With Phagocytic Agonists, TLR Ligands and Anti-CD40 Antibody Stimulates Antitumor Immune Response Against Metastatic and CNS Tumors
    Volume: 132 Page(s): 88 - 88
    04/01/2020 Authors: Medina R; Wang H; Uher O; Heiss J; Nduom E; Gilbert M; Terabe M; Ho W; Zenka J; Pacak K
  • Resection of Myxopapillary Ependymoma of the Filum Terminale: 2-Dimensional Operative Video.
    Oper Neurosurg (Hagerstown) Volume: 18 Page(s): E40
    02/01/2020 Authors: Mastorakos P; Lynes J; Maggio D; Quezado MM; Nduom EK
  • Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy.
    Front Oncol Volume: 10 Page(s): 601452
    01/01/2020 Authors: Yu G; Butler MK; Abdelmaksoud A; Pang Y; Su Y-T; Rae Z; Dadkhah K; Kelly MC; Song YK; Wei JS
  • Cytokine Microdialysis for real-time immune monitoring in Glioblastoma patients undergoing Checkpoint Blockade
    Volume: 7
    11/06/2019 Authors: Lynes J; Sanchez V; Nwankwo A; Dominah G; Wang X; Kunnath I; Dill S; Scott G; Hayes C; Wu T
  • LONG NON-CODING RNA EXPRESSION DIFFERS BETWEEN GLIOBLASTOMA PATIENT IMMUNE CELLS AND HEALTHY VOLUNTEERS
    Volume: 21 Page(s): 253 - 253
    11/01/2019 Authors: Nwankwo A; Sanchez V; Lynes J; Wang X; Dominah G; Obungu A; Edwards N; Sarpong K; Ariyo O; Johnson K
  • A TWITTER-BASED NETWORK ANALYSIS OF BRAIN TUMOR SOCIAL MEDIA (#BTSM)
    Volume: 21 Page(s): 81 - 81
    11/01/2019 Authors: Feliciano J; Salmi L; Blotner C; Hayden A; Nduom E; Kwan B; Katz M; Claus E
  • Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.
    JCI Insight Volume: 4
    10/17/2019 Authors: Giles AJ; Hao S; Padget M; Song H; Zhang W; Lynes J; Sanchez V; Liu Y; Jung J; Cao X
  • The Luciferase-Expressing Glioma-261 Murine Models Elicit an Immune-Mediated Antitumor Response
    Volume: 66 Page(s): 169 - 170
    09/01/2019 Authors: Sanchez VE; Lynes J; Walbridge S; Wang X; Edwards NA; Nwankwo A; Dominah G; Obungu A; Adamstein N; Dagur P
  • Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma.
    Neurosurgery Volume: 85 Page(s): 280 - 289
    08/01/2019 Authors: Pratt D; Dominah G; Lobel G; Obungu A; Lynes J; Sanchez V; Adamstein N; Wang X; Edwards NA; Wu T
  • Returns to Operating Room After Neurosurgical Procedures in a Tertiary Care Academic Medical Center: Implications for Health Care Policy and Quality Improvement COMMENT
    NEUROSURGERY Volume: 84 Page(s): E400 - E401
    06/01/2019 Authors: Kolias AG; Nduom EK-E; Keating R
  • Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade.
    Neurosurgery Volume: 84 Page(s): 945 - 953
    04/01/2019 Authors: Lynes J; Jackson S; Sanchez V; Dominah G; Wang X; Kuek A; Hayes CP; Benzo S; Scott GC; Chittiboina P
  • Young Neurosurgeons Committee of the American Association of Neurological Surgeons: Training Ground for Future Leaders in Organized Neurosurgery in the United States of America.
    World Neurosurg Volume: 123 Page(s): 59 - 63
    03/01/2019 Authors: Linzey JR; Sivakumar W; Johnson JN; Ivan ME; Haider AS; Philips CA; Than KD; Tomei KL; Muraszko KM; Nduom EK
  • Quality Reporting in Neurological Surgery: Practice Adherence to Quality Payment Program Guidelines COMMENTS
    NEUROSURGERY Volume: 84 Page(s): 542 - 543
    02/01/2019 Authors: Vaz-Guimaraes F; Fuentes A; Nduom EK-E
  • GLIOMA-261 LUCIFERASE-EXPRESSING CELL LINE STIMULATES AN IMMUNOGENIC RESPONSE SIGNATURE IN AN IMMUNOCOMPETENT MURINE MODEL
    Volume: 20 Page(s): 269 - 269
    11/01/2018 Authors: Sanchez V; Lynes J; Dominah G; Wang X; Obungu A; Walbridge S; Edwards N; Nduom E
  • SINGLE-CELL PROTEOMIC ANALYSIS OF IMMUNE CELL RESPONSE TO CHECKPOINT BLOCKADE USING 30-PARAMETER FLOW CYTOMETRY
    Volume: 20 Page(s): 137 - 137
    11/01/2018 Authors: Giles A; Nettey L; Liechti T; Beddall M; Vera E; Park D; Wu J; Theeler B; Siegel C; Boris L
  • MUTATIONS IN MAPK PATHWAY GENES ARE CHARACTERISTIC AND CONFIRMATORY OF MULTINODULAR AND VACUOLATING NEURONAL TUMOR OF THE CEREBRUM
    Volume: 20 Page(s): 241 - 241
    11/01/2018 Authors: Aboud O; Raffeld M; Brown J; Sabersky A; Briceno N; Brown M; Chung H-J; Crandon S; Ji M; Levine J
  • Papillary Tumor of The Pineal Region: A Case Report Including Detailed IHC and Molecular Evaluation
    Volume: 77 Page(s): 520 - 520
    06/01/2018 Authors: Powers A; Quezado M; Monroe C; Nduom E; Ray-Chaudhury A; Gilbert M; Raffeld M; Armstrong T; Crandon S; Vera E
  • Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases.
    BMC Cancer Volume: 18 Page(s): 239
    03/01/2018 Authors: Ranjan S; Quezado M; Garren N; Boris L; Siegel C; Lopes Abath Neto O; Theeler BJ; Park DM; Nduom E; Zaghloul KA
  • The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma.
    Fluids Barriers CNS Volume: 15 Page(s): 2
    01/15/2018 Authors: Jackson S; Weingart J; Nduom EK; Harfi TT; George RT; McAreavey D; Ye X; Anders NM; Peer C; Figg WD
  • Current Options and Future Directions in Immune Therapy for Glioblastoma.
    Front Oncol Volume: 8 Page(s): 578
    01/01/2018 Authors: Lynes J; Sanchez V; Dominah G; Nwankwo A; Nduom E
  • THE EFFECT OF REGADENOSON ON TEMOZOLOMIDE NEUROPHARMACOKINETICS IN GLIOBLASTOMA PATIENTS MEASURED BY INTRACEREBRAL MICRODIALYSIS
    Volume: 19 Page(s): 19 - 19
    11/01/2017 Authors: Jackson S; Weingart J; Nduom E; Holdhoff M; Blakeley J; Piotrowski AF; Abd T; George R; McAreavey D; Ye X
  • UPREGULATION OF THE TGF-beta PATHWAY DRIVES TRANSFORMATION OF GLIOBLASTOMA INTO GLIOSARCOMA AND OSTEOSARCOMA
    Volume: 19 Page(s): 35 - 35
    11/01/2017 Authors: Li A; Ranjan S; Ahn S; Celiku O; Kim SA; Quezado M; Nduom E; Gilbert MR; Park DM
  • VALIDATION OF PD-L1 EXPRESSION IN HIGH GRADE GLIOMAS AS AN INDEPENDENT NEGATIVE PROGNOSTIC MARKER
    Volume: 19 Page(s): 112 - 112
    11/01/2017 Authors: Pratt D; Dominah G; Lobel G; Obungu A; Wang X; Edwards NA; Maric D; Gilbert MR; Quezado M; Nduom EK
  • Immune modulatory nanoparticle therapeutics for intracerebral glioma.
    Neuro Oncol Volume: 19 Page(s): 372 - 382
    03/01/2017 Authors: Yaghi NK; Wei J; Hashimoto Y; Kong L-Y; Gabrusiewicz K; Nduom EK; Ling X; Huang N; Zhou S; Kerrigan BCP
  • MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
    Neuro Oncol Volume: 18 Page(s): 639 - 648
    05/01/2016 Authors: Wei J; Nduom EK; Kong L-Y; Hashimoto Y; Xu S; Gabrusiewicz K; Ling X; Huang N; Qiao W; Zhou S
  • PD-L1 expression and prognostic impact in glioblastoma.
    Neuro Oncol Volume: 18 Page(s): 195 - 205
    02/01/2016 Authors: Nduom EK; Wei J; Yaghi NK; Huang N; Kong L-Y; Gabrusiewicz K; Ling X; Zhou S; Ivan C; Chen JQ
  • Immunosuppressive mechanisms in glioblastoma.
    Neuro Oncol Volume: 17 Suppl 7 Page(s): vii9 - vii14
    11/01/2015 Authors: Nduom EK; Weller M; Heimberger AB
  • An optimized therapeutic nanoparticle delivery platform of miRNA in preclinical murine models of malignancy
    Volume: 75
    08/01/2015 Authors: Yaghi NK; Wei J; Kong L-Y; Hashimoto Y; Nduom EK; Huang N; Ling X; Zhou S; Levine JM; Fajt VR
  • miR-138 exerts anti-glioma efficacy by targeting immune checkpoints
    Volume: 122 Page(s): 613 - 613
    05/01/2015 Authors: Nduom EK-E; Wei J; Kong L-Y; Xu S; Gabrusiewicz K; Ling X; Huang N; Ivan C; Chen JQ; Radvanyi L
  • TARGETING THE IMMUNE CHECKPOINT NETWORK WITH miR-138 EXERTS THERAPEUTIC EFFICACY IN MURINE MODELS OF GLIOMA
    Volume: 16
    11/01/2014 Authors: Nduom EK; Wei J; Kong L-Y; Xu S; Gabrusiewicz K; Ling X; Huang N; Qiao W; Zhou S; Ivan C
  • TARGETING THE IMMUNE CHECKPOINT NETWORK WITH MIR-138 EXERTS THERAPEUTIC EFFICACY IN MURINE MODELS OF GLIOMA
    Volume: 16
    09/01/2014 Authors: Heimberger A; Wei J; Nduom E; Kong L; Ivan C; Fuller GN; Gilbert MR; Conrad CA; Calin GA
  • Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
    J Natl Cancer Inst Volume: 106
    08/01/2014 Authors: Xu S; Wei J; Wang F; Kong L-Y; Ling X-Y; Nduom E; Gabrusiewicz K; Doucette T; Yang Y; Yaghi NK
  • Blood-brain barrier. Response.
    J Neurosurg Volume: 120 Page(s): 291
    01/01/2014 Authors: Nduom EK; Zhuang Z; Lonser RR
  • Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.
    J Neurosurg Volume: 119 Page(s): 427 - 433
    08/01/2013 Authors: Nduom EK; Yang C; Merrill MJ; Zhuang Z; Lonser RR
  • Imaging detection of endolymphatic sac tumor-associated hydrops.
    J Neurosurg Volume: 119 Page(s): 406 - 411
    08/01/2013 Authors: Butman JA; Nduom E; Kim HJ; Lonser RR
  • Neuroendoscopic Resection of Intraventricular Tumors and Cysts through a Working Channel with a Variable Aspiration Tissue Resector: A Feasibility and Safety Study.
    Minim Invasive Surg Volume: 2013 Page(s): 471805
    01/01/2013 Authors: Nduom EK-E; Sribnick EA; Ormond DR; Hadjipanayis CG
  • Comparison of pulsed versus continuous convective flow for central nervous system tissue perfusion: laboratory investigation.
    J Neurosurg Volume: 117 Page(s): 1150 - 1154
    12/01/2012 Authors: Nduom EK; Walbridge S; Lonser RR
  • Nanotechnology applications for glioblastoma.
    Neurosurg Clin N Am Volume: 23 Page(s): 439 - 449
    07/01/2012 Authors: Nduom EK; Bouras A; Kaluzova M; Hadjipanayis CG
  • Canine model of convection-enhanced delivery of cetuximab-conjugated iron-oxide nanoparticles monitored with magnetic resonance imaging.
    Clin Neurosurg Volume: 59 Page(s): 107 - 113
    01/01/2012 Authors: Platt S; Nduom E; Kent M; Freeman C; Machaidze R; Kaluzova M; Wang L; Mao H; Hadjipanayis CG
  • Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
    Cancer J Volume: 18 Page(s): 100 - 106
    01/01/2012 Authors: Nduom EK-E; Hadjipanayis CG; Van Meir EG
  • IMAGING, TARGETED THERAPY, AND IDENTIFICATION OF CANDIDATE PROTEINS OF GLIOMA STEM CELLS. EGFRVIII ANTIBODY-CONJUGATED MAGNETIC NANOPARTICLES INHIBIT FORMATION AND PROLIFERATION OF GBM-DERIVED NEUROSPHERES
    Volume: 12 Page(s): 125 - 125
    11/01/2010 Authors: Kaluzova M; Machaidze R; Nduom ENK; Burden CT; Hadjipanayis CG
  • CONVECTION ENHANCED DELIVERY OF MAYTANSINOID NANOPARTICLES FOR TREATMENT OF GLIOBLASTOMA MULTIFORME
    Volume: 12 Page(s): 93 - 93
    11/01/2010 Authors: Nduom E; Machaidze R; Kaluzova M; Wang Y; Nie S; Hadjipanayis C
  • Acute lung injury is an independent risk factor for brain hypoxia after severe traumatic brain injury.
    Neurosurgery Volume: 67 Page(s): 338 - 344
    08/01/2010 Authors: Oddo M; Nduom E; Frangos S; MacKenzie L; Chen I; Maloney-Wilensky E; Kofke WA; Levine JM; LeRoux PD
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements